Jenna Harris Starko, WHNP
Women'S Health · Los Altos Hills
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Jenna Harris Starko’s office at (832) 454-1048 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their 396 Part D prescriptions in 2022.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2023 | 121 | 45 | None | None | $3,759 |
| 2022 | 396 | 103 | 7% (27) | 13% | $217,429 |
| 2021 | 330 | 92 | 7% (23) | 8% | $115,894 |
| 2020 | 236 | 80 | None | 8% | $75,752 |
| 2019 | 142 | 51 | None | 12% | $5,011 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Estradiol | 13 | $726 | $56 |
2022: 13 drugs
| Premarin | 15 | $6,526 | $435 |
| Gabapentin | 36 | $975 | $27 |
| Celecoxib | 15 | $862 | $57 |
| Ondansetron Odt | 21 | $710 | $34 |
| Pantoprazole | 19 | $192 | $10 |
| Levothyroxine | 18 | $142 | $8 |
| Dexamethasone | 19 | $137 | $7 |
| Mirtazapine | 12 | $131 | $11 |
| Fluconazole | 18 | $116 | $6 |
| Ibuprofen | 15 | $83 | $6 |
| Sertraline | 16 | $67 | $4 |
| Ciprofloxacin | 11 | $36 | $3 |
| Tramadol | 18 | $36 | $2 |
2021: 8 drugs
| Estradiol | 14 | $1,899 | $136 |
| Gabapentin | 54 | $631 | $12 |
| Ondansetron Odt | 17 | $390 | $23 |
| Famotidine | 12 | $208 | $17 |
| Sertraline | 23 | $193 | $8 |
| Pantoprazole | 14 | $187 | $13 |
| Fluconazole | 14 | $91 | $6 |
| Tramadol | 15 | $56 | $4 |
2020: 4 drugs
| Gabapentin | 27 | $317 | $12 |
| Tamoxifen Citrate | 15 | $123 | $8 |
| Fluconazole | 14 | $75 | $5 |
| Ibuprofen | 14 | $67 | $5 |
2019: 2 drugs
| Gabapentin | 11 | $181 | $16 |
| Ibuprofen | 14 | $58 | $4 |
Money from drug and device companies
$25 in 2025
| 2025 | 1 | 1 | None | $25 |
| 2023 | 12 | 14 | None | $707 |
| 2022 | 18 | 52 | None | $623 |
| 2021 | 12 | 42 | None | $301 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | Kisqali | $25 | 1 payment
|
See the published payment
| Novartis Pharmaceuticals | Meals · 2025-04-22 | Kisqali | $25 |
See earlier years (2023, 2022, 2021)
2023: $707
| Merz North America | Xeomin | $335 | 1 payment
|
| Myriad Genetic Laboratories | Myrisk | $112 | 2 payments
|
| Pfizer | Ibrance | $43 | 2 payments
|
| Ethicon US | Stratafix | $40 | 1 payment
|
| CTI BioPharma | Vonjo | $24 | 1 payment
|
| Novartis Pharmaceuticals | Kisqali | $24 | 1 payment
|
| Eisai | Lenvima | $24 | 1 payment
|
| Janssen Biotech | Erleada | $22 | 1 payment
|
| Taiho Oncology | Lonsurf | $22 | 1 payment
|
| Amgen | Kyprolis | $21 | 1 payment
|
| MorphoSys US | Monjuvi | $21 | 1 payment
|
| Puma Biotechnology | None | $20 | 1 payment
|
2022: $623
| Novartis Pharmaceuticals | Kisqali | $108 | 5 payments
|
| GlaxoSmithKline | Zejula | $66 | 2 payments
|
| Myriad Genetic Laboratories | Myrisk | $54 | 3 payments
|
| Janssen Biotech | Erleada | $46 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $44 | 2 payments
|
| Amgen | Kyprolis | $43 | 2 payments
|
| Lilly USA | Verzenio | $34 | 1 payment
|
| Genmab U.S. | Tivdak | $34 | 2 payments
|
| Tactile Systems Technology | Flexitouch Plus | $27 | 2 payments
|
| Ethicon US | Enseal | $24 | 1 payment
|
| Rigel Pharmaceuticals | Tavalisse | $22 | 1 payment
|
| Pharmacyclics LLC an AbbVie | Imbruvica | $22 | 1 payment
|
| Incyte | Monjuvi | $19 | 1 payment
|
| Eisai | Lenvima | $18 | 1 payment
|
| MorphoSys US | Monjuvi | $17 | 1 payment
|
| Myovant Sciences | Myfembree | $17 | 1 payment
|
| Pfizer | Ibrance | $15 | 1 payment
|
| Seagen | Padcev | $14 | 1 payment
|
2021: $301
| AstraZeneca Pharmaceuticals LP | Lynparza | $48 | 3 payments
|
| Merck Sharp & Dohme | Lynparza | $42 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $37 | 2 payments
|
| Daiichi Sankyo | Enhertu | $37 | 2 payments
|
| GlaxoSmithKline | Zejula | $26 | 1 payment
|
| Seagen | Padcev | $24 | 1 payment
|
| MorphoSys US | Monjuvi | $18 | 1 payment
|
| Myriad Genetic Laboratories | Myrisk | $15 | 1 payment
|
| Janssen Biotech | Erleada | $15 | 1 payment
|
| Eisai | Lenvima | $13 | 1 payment
|
| Ipsen Biopharmaceuticals | Somatuline Depot | $13 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $12 | 1 payment
|
Professional record
- NPI
- 1255769238
- Licence
- TX 158893, TX AP124715
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LW0102X (363LW0102X); Nurse practitioner (363L00000X)
- Mailing address
- 14355 Miranda Way, Los Altos Hills, CA, 94022
- NPI first listed
- 2013-10-29
- NPI last updated
- 2023-09-05
- NPI record certified
- 2023-09-05
This is when the NPI record was last certified, not a medical board exam.